Day: April 4, 2025

ZEELAND, Mich., April 04, 2025 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, fire protection technologies and consumer electronics, is pleased to announce that it will release its first quarter 2025 financial results on Friday, April 25, before the market opens. The Company will host a conference call for the investment community at 9:30am ET to discuss the results. The call will also be available to the general public via a live audio webcast. Participants who wish to ask questions may register for the call at the following URL to receive the dial-in numbers and unique PIN: https://register-conf.media-server.com/register/BId5094df774c442c5bda50fc086190a0e. It is recommended that participants join 10 minutes prior to the event start,...

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (the “Company” or “Entourage”) is pleased to announce the closing of the previously announced plan of arrangement (the “Arrangement”) pursuant to which 1001095275 Ontario Inc. (the “Purchaser”), a related party of LiUNA Pension Fund of Central and Eastern Canada (“LiUNA”), acquired, with an effective date of March 31, 2025 (the “Effective Date”), all of the issued and outstanding common shares of the Company (the “Common Shares”) for cash consideration equal to C$0.005 per Common Share (the “Consideration”). The Arrangement also provided for the same Consideration to be paid to holders of certain vested convertible securities of the Company. In addition, in connection with the Arrangement, the Company previously entered into...

Geneva, Switzerland, April 04, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today confirmed that its operations are unaffected by the Trump administration’s recently announced tariffs. An exemption on semiconductors under the current trade policy means the Company faces no impact at this stage, while its business is bolstered by the innovation strategy, U.S. development roadmap, and leadership in post-quantum cryptography—which is soon expected to become a legal compliance requirement under a U.S. executive order. On April 2, 2025, the U.S. administration introduced its “Fair and Reciprocal Plan,” setting a 10% tariff on most imports and higher rates...

JACKSONVILLE, Fla., April 04, 2025 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its first quarter 2025 earnings results on Tuesday, April 29, 2025, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Wednesday, April 30, 2025, at 11:00 a.m. ET.First Quarter 2025 Earnings Conference CallDate: Wednesday, April 30, 2025Time: 11:00 a.m. ETDial#: 877-407-0789 or 201-689-8562Webcast: 1st Quarter 2025 Webcast Link   Replay Webcast Archive: Investor Relations page under Webcasts & Presentations About Regency Centers Corporation (NASDAQ: REG) Regency...

ATLANTA, April 04, 2025 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a global leader in energy and industrial gas solutions, has scheduled a conference call for Thursday, May 1, 2025 at 8:30 a.m. ET to discuss its first quarter 2025 financial results. Chart plans to issue its first quarter 2025 earnings release prior to market open on May 1st. Participants wishing to join the live Q&A session must dial-in with the following information: PARTICIPANT INFORMATION:Toll Free – North America: (+1) 800 549 8228Toll – North America and other locations: (+1) 289 819 1520 A live webcast and replay, as well as presentation slides, will be available on the Company’s investor relations website through the following link: Q1 2025 Earnings Webcast. A telephone replay of the conference call can be accessed approximately...

– Data demonstrate that ARV-102 was well tolerated, orally bioavailable, and brain-penetrant; ARV-102 achieved central and peripheral LRRK2 reduction indicating substantial LRRK2 protein degradation in healthy volunteers – – Findings support continued evaluation of ARV-102 in neurodegenerative diseases associated with LRRK2 dysfunction; a Phase 1 trial in patients with Parkinson’s disease has been initiated and is currently enrolling – NEW HAVEN, Conn., April 04, 2025 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today presented data from the first-in-human clinical trial of ARV-102, the Company’s investigational PROteolysis TArgeting Chimera (PROTAC) leucine-rich repeat kinase 2 (LRRK2) degrader. In the...

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) — Rogers Communications Inc. (TSX: RCI.A and RCI.B; NYSE: RCI) (“Rogers”) today announced that it has commenced consent solicitations to amend the indentures governing certain of its outstanding US dollar-denominated and Canadian dollar-denominated notes, including notes originally issued by Shaw Communications Inc. (collectively the “Consent Solicitations”), as listed in the table below (the “Notes”). The Consent Solicitations are being made in connection with the subsidiary equity investment announced today by Rogers and Blackstone. Rogers intends to use substantially all of the net proceeds of the subsidiary equity investment to repay debt. The subsidiary equity investment will be reported as equity in Rogers’ consolidated financial statements, and is expected to be considered an equity...